Cormorant Asset Management »

Cargo Therapeutics shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Cargo Therapeutics (CRGX) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Cargo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cargo Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cargo Therapeutics by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $19M 1.2M 16.42
2024-03-31 $26M 1.2M 22.32
2023-12-31 $27M 1.2M 23.15

More positions owned by Cormorant Asset Management

Moonlake Immunotherapeutics Class A Ord (MLTX)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Arcellx Common Stock (ACLX)
Vaxcyte (PCVX)
Longboard Pharmaceuticals In (LBPH)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Merus N V (MRUS)
Bridgebio Pharma (BBIO)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Janux Therapeutics (JANX)
Axsome Therapeutics (AXSM)

View all positions for Cormorant Asset Management

Top funds holding Cargo Therapeutics

Samsara BioCapital
Perceptive Advisors
T. Rowe Price Associates
Nextech Invest
Henderson Group
BlackRock
Novo A/S
EcoR1 Capital
Vanguard Group
BlackRock
Cormorant Asset Management
Woodline Partners
Saturn V Capital Management
Geode Capital Management
State Street Corporation

View all funds holding Cargo Therapeutics